JK
Insider
Julie Krop
DirectorJulie Krop (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Aquestive Therapeutics, Inc. (AQST). The largest single filing was $125K of AQST (25,000 sh × $5.02, as filed), executed Jun 23.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$125K
shares × price, as filed
Last traded
Jun 23
Filed Jun 24
Median ADV $10.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $125K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AQST
Aquestive Therapeutics, Inc.
AQST · 0 buys · 1 sell
1 filing
Recent filings
AQSTSALE
Aquestive Therapeutics, Inc.
View filing →
$125K25,000 sh × $5.02
Exec Jun 23
Filed Jun 24 · 5:30 PM ET